Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TCRXTCRX
Showing 8 of 20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TSCAN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 584,811 shares of TCRX (TSCAN THERAPEUTICS INC), worth $573,401 as of 2026-Q2. The position was decreased (-5.2% shares).

Current Value

$573,401

Current Shares

584,811

Total Value Change

-$4.3M

Total Shares Change

-388,655

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
584,811
-5.2%
$573,4010.0%$0.98
0
2026-Q1
Increased
616,952
+9.8%
$623,3400.0%$1.03
18
2025-Q4
Decreased
562,153
-1.0%
$562,3600.0%$1.03
0
2025-Q3
Increased
567,657
+0.2%
$1M0.0%$1.74
25
2025-Q2
Decreased
566,371
-44.2%
$821,5290.0%$1.40
0
2025-Q1
Increased
1M
+5.4%
$1.4M0.0%$1.35
27
2024-Q4
Decreased
963,257
-1.1%
$2.9M0.0%$3.00
0
2024-Q3
Increased
973,466
+8.1%
$4.8M0.0%$5.04
29

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used